{"id":2772,"date":"2019-07-12T00:54:00","date_gmt":"2019-07-12T04:54:00","guid":{"rendered":"https:\/\/www.cannara.ca\/?p=2772"},"modified":"2026-04-07T01:10:41","modified_gmt":"2026-04-07T05:10:41","slug":"cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78","status":"publish","type":"post","link":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/","title":{"rendered":"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d&rsquo;actions ordinaires"},"content":{"rendered":"\n<p><strong><em>VANCOUVER \u2013 12 juill. 2019<\/em><\/strong> \u2013 Cannara&nbsp;Biotech&nbsp;Inc. (la \u00ab&nbsp;<strong>Soci\u00e9t\u00e9<\/strong>&nbsp;\u00bb ou \u00ab&nbsp;<strong>Cannara<\/strong>&nbsp;\u00bb) (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), une entreprise de cannabis \u00e9mergente int\u00e9gr\u00e9e verticalement ax\u00e9e sur la culture et les produits infus\u00e9s au cannabis, est heureuse d&rsquo;annoncer qu&rsquo;elle a amass\u00e9 2&nbsp;160&nbsp;000&nbsp;$ au moyen d&rsquo;un placement priv\u00e9 d&rsquo;actions ordinaires sans interm\u00e9diaire de la Soci\u00e9t\u00e9 (s\u00e9par\u00e9ment, une \u00ab&nbsp;action ordinaire&nbsp;\u00bb et collectivement, les \u00ab&nbsp;actions ordinaires&nbsp;\u00bb) au prix de 0,18&nbsp;$ par action ordinaire (le \u00ab&nbsp;placement&nbsp;\u00bb). Le produit net du placement servira aux activit\u00e9s g\u00e9n\u00e9rales de l&rsquo;entreprise, y compris l&rsquo;am\u00e9nagement des installations de Cannara ainsi que de miser sur de nouveaux fonds de roulement.<\/p>\n\n\n\n<p>Le placement devrait \u00eatre conclu aux alentours du 20&nbsp;juillet&nbsp;2019 (la \u00ab&nbsp;date de conclusion&nbsp;\u00bb), et il demeure soumis \u00e0 l&rsquo;approbation du march\u00e9 boursier canadien.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">CONTACT<\/h2>\n\n\n\n<p>Zohar Krivorot<br>Fondateur et PDG<br><a href=\"mailto:zohar@cannara.ca\">zohar@cannara.ca<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">CANNARA BIOTECH<\/h2>\n\n\n\n<p>Cannara&nbsp;Biotech (CSE: LOVE) proc\u00e8de \u00e0 la construction de l&rsquo;une des installations de culture int\u00e9rieure de cannabis les plus importantes au&nbsp;Canada&nbsp;et la plus vaste au Qu\u00e9bec (625&nbsp;000&nbsp;pieds carr\u00e9s). Tirant parti des faibles co\u00fbts d&rsquo;\u00e9lectricit\u00e9 au Qu\u00e9bec, l&rsquo;installation de Cannara&nbsp;Biotech produira du cannabis cultiv\u00e9 \u00e0 l&rsquo;int\u00e9rieur, ainsi que des produits infus\u00e9s au cannabis de qualit\u00e9 sup\u00e9rieure destin\u00e9s aux march\u00e9s canadiens et internationaux.<\/p>\n\n\n\n<p><strong><em>Le march\u00e9 boursier canadien et son fournisseur de services de r\u00e9glementation n&rsquo;assument aucune responsabilit\u00e9 quant \u00e0 la pertinence ou \u00e0 l&rsquo;exactitude du pr\u00e9sent communiqu\u00e9.<\/em><\/strong><\/p>\n\n\n\n<p><strong>Mise en garde concernant les \u00ab&nbsp;renseignements prospectifs&nbsp;\u00bb<\/strong><\/p>\n\n\n\n<p><em>Le pr\u00e9sent communiqu\u00e9 contient certains renseignements prospectifs. De tels renseignements comportent des risques connus et inconnus, des incertitudes et d&rsquo;autres facteurs qui pourraient faire en sorte que les r\u00e9sultats, les rendements ou les r\u00e9alisations r\u00e9els divergent substantiellement de ceux sous-entendus dans les \u00e9nonc\u00e9s aux pr\u00e9sentes. Donc, ces \u00e9nonc\u00e9s ne devraient pas \u00eatre per\u00e7us comme des garanties de rendements ou r\u00e9sultats futurs. Tous les \u00e9nonc\u00e9s prospectifs sont fond\u00e9s sur les croyances actuelles de la Soci\u00e9t\u00e9, sur ses suppositions et sur les renseignements actuellement disponibles, ainsi que sur d&rsquo;autres facteurs. Les lecteurs sont pri\u00e9s de ne pas se fier ind\u00fbment \u00e0 ces \u00e9nonc\u00e9s prospectifs, qui ne sont pertinents qu&rsquo;\u00e0 la date de publication de ce communiqu\u00e9 de presse. En raison des risques et des incertitudes, incluant ceux identifi\u00e9s par la Soci\u00e9t\u00e9 dans ses documents publics d\u00e9pos\u00e9s, les \u00e9v\u00e9nements r\u00e9els peuvent diff\u00e9rer de fa\u00e7on consid\u00e9rable des attentes actuelles. La Soci\u00e9t\u00e9 n&rsquo;assume aucune obligation ou intention quant \u00e0 la mise \u00e0 jour ou \u00e0 la r\u00e9vision des \u00e9nonc\u00e9s prospectifs, que ce soit \u00e0 la lumi\u00e8re de nouvelles informations, d&rsquo;\u00e9v\u00e9nements futurs ou d&rsquo;autres \u00e9l\u00e9ments.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER \u2013 12 juill. 2019 \u2013 Cannara&nbsp;Biotech&nbsp;Inc. (la \u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb ou \u00ab&nbsp;Cannara&nbsp;\u00bb) (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), une entreprise de cannabis \u00e9mergente int\u00e9gr\u00e9e verticalement ax\u00e9e sur la culture et les produits infus\u00e9s au cannabis, est heureuse d&rsquo;annoncer qu&rsquo;elle a amass\u00e9 2&nbsp;160&nbsp;000&nbsp;$ au moyen d&rsquo;un placement priv\u00e9 d&rsquo;actions ordinaires sans interm\u00e9diaire de la Soci\u00e9t\u00e9 (s\u00e9par\u00e9ment, une [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":"","_wpscp_schedule_draft_date":"","_wpscp_schedule_republish_date":"","_wpscppro_advance_schedule":false,"_wpscppro_advance_schedule_date":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"default","_twitter_share_type":"default","_linkedin_share_type":"default","_pinterest_share_type":"default","_linkedin_share_type_page":"default","_instagram_share_type":"default","_medium_share_type":"default","_threads_share_type":"default","_google_business_share_type":"default","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[30],"tags":[],"class_list":["post-2772","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d&#039;actions ordinaires - Cannara Biotech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d&#039;actions ordinaires - Cannara Biotech\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER \u2013 12 juill. 2019 \u2013 Cannara&nbsp;Biotech&nbsp;Inc. (la \u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb ou \u00ab&nbsp;Cannara&nbsp;\u00bb) (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), une entreprise de cannabis \u00e9mergente int\u00e9gr\u00e9e verticalement ax\u00e9e sur la culture et les produits infus\u00e9s au cannabis, est heureuse d&rsquo;annoncer qu&rsquo;elle a amass\u00e9 2&nbsp;160&nbsp;000&nbsp;$ au moyen d&rsquo;un placement priv\u00e9 d&rsquo;actions ordinaires sans interm\u00e9diaire de la Soci\u00e9t\u00e9 (s\u00e9par\u00e9ment, une [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannara Biotech\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-12T04:54:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T05:10:41+00:00\" \/>\n<meta name=\"author\" content=\"cannaraadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cannaraadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/\"},\"author\":{\"name\":\"cannaraadmin\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/person\\\/3aaaabd90bd805cac77b57ae47bf0f91\"},\"headline\":\"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d&rsquo;actions ordinaires\",\"datePublished\":\"2019-07-12T04:54:00+00:00\",\"dateModified\":\"2026-04-07T05:10:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/\"},\"wordCount\":507,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\"},\"articleSection\":[\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/\",\"name\":\"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d'actions ordinaires - Cannara Biotech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#website\"},\"datePublished\":\"2019-07-12T04:54:00+00:00\",\"dateModified\":\"2026-04-07T05:10:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2019\\\/07\\\/12\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d&#8217;actions ordinaires\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\",\"name\":\"Cannara Biotech\",\"description\":\"Premium Quality Cannabis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\",\"name\":\"Cannara Biotech\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Cannara_LogoV1_500pxT.png\",\"contentUrl\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Cannara_LogoV1_500pxT.png\",\"width\":500,\"height\":135,\"caption\":\"Cannara Biotech\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/person\\\/3aaaabd90bd805cac77b57ae47bf0f91\",\"name\":\"cannaraadmin\",\"sameAs\":[\"https:\\\/\\\/www.cannara.ca\"],\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/author\\\/cannaraadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d'actions ordinaires - Cannara Biotech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/","og_locale":"fr_FR","og_type":"article","og_title":"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d'actions ordinaires - Cannara Biotech","og_description":"VANCOUVER \u2013 12 juill. 2019 \u2013 Cannara&nbsp;Biotech&nbsp;Inc. (la \u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb ou \u00ab&nbsp;Cannara&nbsp;\u00bb) (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), une entreprise de cannabis \u00e9mergente int\u00e9gr\u00e9e verticalement ax\u00e9e sur la culture et les produits infus\u00e9s au cannabis, est heureuse d&rsquo;annoncer qu&rsquo;elle a amass\u00e9 2&nbsp;160&nbsp;000&nbsp;$ au moyen d&rsquo;un placement priv\u00e9 d&rsquo;actions ordinaires sans interm\u00e9diaire de la Soci\u00e9t\u00e9 (s\u00e9par\u00e9ment, une [&hellip;]","og_url":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/","og_site_name":"Cannara Biotech","article_published_time":"2019-07-12T04:54:00+00:00","article_modified_time":"2026-04-07T05:10:41+00:00","author":"cannaraadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cannaraadmin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/#article","isPartOf":{"@id":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/"},"author":{"name":"cannaraadmin","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/person\/3aaaabd90bd805cac77b57ae47bf0f91"},"headline":"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d&rsquo;actions ordinaires","datePublished":"2019-07-12T04:54:00+00:00","dateModified":"2026-04-07T05:10:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/"},"wordCount":507,"publisher":{"@id":"https:\/\/www.cannara.ca\/fr\/#organization"},"articleSection":["Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/","url":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/","name":"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d'actions ordinaires - Cannara Biotech","isPartOf":{"@id":"https:\/\/www.cannara.ca\/fr\/#website"},"datePublished":"2019-07-12T04:54:00+00:00","dateModified":"2026-04-07T05:10:41+00:00","breadcrumb":{"@id":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cannara.ca\/fr\/2019\/07\/12\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-78\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cannara.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Cannara Biotech annonce un placement priv\u00e9 sans interm\u00e9diaire de 12 000 000 d&#8217;actions ordinaires"}]},{"@type":"WebSite","@id":"https:\/\/www.cannara.ca\/fr\/#website","url":"https:\/\/www.cannara.ca\/fr\/","name":"Cannara Biotech","description":"Premium Quality Cannabis","publisher":{"@id":"https:\/\/www.cannara.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cannara.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cannara.ca\/fr\/#organization","name":"Cannara Biotech","url":"https:\/\/www.cannara.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/10\/Cannara_LogoV1_500pxT.png","contentUrl":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/10\/Cannara_LogoV1_500pxT.png","width":500,"height":135,"caption":"Cannara Biotech"},"image":{"@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/person\/3aaaabd90bd805cac77b57ae47bf0f91","name":"cannaraadmin","sameAs":["https:\/\/www.cannara.ca"],"url":"https:\/\/www.cannara.ca\/fr\/author\/cannaraadmin\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts\/2772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/comments?post=2772"}],"version-history":[{"count":0,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts\/2772\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/media?parent=2772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/categories?post=2772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/tags?post=2772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}